日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/02/16 | 6,190 | 6,310 | 6,180 | 6,250 | +90 | +1.5% | 199,700 |
| 2018/02/15 | 6,080 | 6,210 | 6,080 | 6,160 | +100 | +1.7% | 304,000 |
| 2018/02/14 | 6,260 | 6,260 | 6,050 | 6,060 | -200 | -3.2% | 425,700 |
| 2018/02/13 | 6,420 | 6,430 | 6,230 | 6,260 | -130 | -2% | 414,400 |
| 2018/02/09 | 6,470 | 6,470 | 6,270 | 6,390 | -300 | -4.5% | 328,300 |
| 2018/02/08 | 6,750 | 6,780 | 6,650 | 6,690 | ±0 | ±0% | 292,000 |
| 2018/02/07 | 6,940 | 7,030 | 6,660 | 6,690 | -230 | -3.3% | 542,100 |
| 2018/02/06 | 6,960 | 7,000 | 6,760 | 6,920 | -440 | -6% | 334,500 |
| 2018/02/05 | 7,460 | 7,530 | 7,350 | 7,360 | -250 | -3.3% | 167,400 |
| 2018/02/02 | 7,600 | 7,640 | 7,530 | 7,610 | -20 | -0.3% | 222,300 |
| 2018/02/01 | 7,550 | 7,630 | 7,520 | 7,630 | +120 | +1.6% | 149,100 |
| 2018/01/31 | 7,580 | 7,670 | 7,510 | 7,510 | -120 | -1.6% | 275,300 |
| 2018/01/30 | 7,710 | 7,770 | 7,600 | 7,630 | -110 | -1.4% | 228,400 |
| 2018/01/29 | 7,800 | 7,870 | 7,720 | 7,740 | -60 | -0.8% | 181,900 |
| 2018/01/26 | 7,880 | 7,890 | 7,770 | 7,800 | +10 | +0.1% | 217,200 |
| 2018/01/25 | 7,900 | 7,950 | 7,760 | 7,790 | -70 | -0.9% | 219,500 |
| 2018/01/24 | 7,990 | 8,020 | 7,800 | 7,860 | -190 | -2.4% | 432,500 |
| 2018/01/23 | 8,100 | 8,120 | 8,030 | 8,050 | ±0 | ±0% | 189,800 |
| 2018/01/22 | 8,040 | 8,080 | 8,020 | 8,050 | -30 | -0.4% | 167,200 |
| 2018/01/19 | 8,020 | 8,150 | 8,020 | 8,080 | +70 | +0.9% | 171,000 |
| 2018/01/18 | 8,110 | 8,150 | 8,010 | 8,010 | -10 | -0.1% | 208,700 |
| 2018/01/17 | 8,050 | 8,190 | 8,000 | 8,020 | -160 | -2% | 276,100 |
| 2018/01/16 | 8,340 | 8,340 | 8,180 | 8,180 | -70 | -0.8% | 279,000 |
| 2018/01/15 | 8,260 | 8,300 | 8,230 | 8,250 | +90 | +1.1% | 112,100 |
| 2018/01/12 | 8,030 | 8,240 | 8,000 | 8,160 | +160 | +2% | 269,300 |
| 2018/01/11 | 8,340 | 8,390 | 7,880 | 8,000 | -490 | -5.8% | 619,800 |
| 2018/01/10 | 8,760 | 8,760 | 8,490 | 8,490 | -270 | -3.1% | 364,500 |
| 2018/01/09 | 8,630 | 8,820 | 8,620 | 8,760 | ±0 | ±0% | 167,500 |
| 2018/01/05 | 8,680 | 8,780 | 8,660 | 8,760 | +90 | +1% | 124,700 |
| 2018/01/04 | 8,500 | 8,680 | 8,450 | 8,670 | +260 | +3.1% | 142,200 |
| 2017/12/29 | 8,440 | 8,470 | 8,390 | 8,410 | ±0 | ±0% | 70,100 |
| 2017/12/28 | 8,400 | 8,500 | 8,370 | 8,410 | +10 | +0.1% | 105,900 |
| 2017/12/27 | 8,430 | 8,450 | 8,370 | 8,400 | -30 | -0.4% | 85,900 |
| 2017/12/26 | 8,430 | 8,520 | 8,410 | 8,430 | +20 | +0.2% | 86,100 |
| 2017/12/25 | 8,310 | 8,480 | 8,310 | 8,410 | +140 | +1.7% | 127,000 |
| 2017/12/22 | 8,130 | 8,330 | 8,110 | 8,270 | +160 | +2% | 158,700 |
| 2017/12/21 | 8,060 | 8,130 | 8,040 | 8,110 | ±0 | ±0% | 147,800 |
| 2017/12/20 | 8,210 | 8,320 | 8,070 | 8,110 | -120 | -1.5% | 190,100 |
| 2017/12/19 | 8,380 | 8,380 | 8,220 | 8,230 | -150 | -1.8% | 97,100 |
| 2017/12/18 | 8,280 | 8,430 | 8,230 | 8,380 | +180 | +2.2% | 162,300 |
| 2017/12/15 | 8,180 | 8,240 | 8,150 | 8,200 | -20 | -0.2% | 134,800 |
| 2017/12/14 | 8,290 | 8,330 | 8,180 | 8,220 | -100 | -1.2% | 159,800 |
| 2017/12/13 | 8,140 | 8,370 | 8,140 | 8,320 | +250 | +3.1% | 301,500 |
| 2017/12/12 | 8,000 | 8,100 | 7,970 | 8,070 | +140 | +1.8% | 171,000 |
| 2017/12/11 | 7,880 | 7,950 | 7,770 | 7,930 | +110 | +1.4% | 138,700 |
| 2017/12/08 | 7,660 | 7,850 | 7,660 | 7,820 | +10 | +0.1% | 176,900 |
| 2017/12/07 | 7,690 | 7,870 | 7,680 | 7,810 | +180 | +2.4% | 149,500 |
| 2017/12/06 | 7,780 | 7,810 | 7,610 | 7,630 | -190 | -2.4% | 168,000 |
| 2017/12/05 | 7,850 | 7,850 | 7,790 | 7,820 | -100 | -1.3% | 211,800 |
| 2017/12/04 | 7,980 | 8,060 | 7,920 | 7,920 | -10 | -0.1% | 125,000 |
1851～
1900
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 374,400円 | +3.8% | -19.9% | 3.63% | 12.16倍 | 0.93倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 203,400円 | +5.9% | +684.6% | 2.70% | 13.50倍 | 1.35倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
